NO953067L - Ekspresjon av beskyttende antigener - Google Patents
Ekspresjon av beskyttende antigenerInfo
- Publication number
- NO953067L NO953067L NO953067A NO953067A NO953067L NO 953067 L NO953067 L NO 953067L NO 953067 A NO953067 A NO 953067A NO 953067 A NO953067 A NO 953067A NO 953067 L NO953067 L NO 953067L
- Authority
- NO
- Norway
- Prior art keywords
- fragment
- antigen
- enzyme
- expression
- integration
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Denne oppfinnelse tilveiebringer en fremgangsmåte for ekspresjon av et enzymantigen som i naturen er et parasitt- tarmmembranbundet eller et fragment derav som har lignende enzym- og/eller antigen-aktivitet, hvori pattedyrvertsceller blir transfektert med en vektor tilpasset til å uttrykke nevnte enzymantigen eller fragment derav, karakterisert ved at vertscellene før transformasjon er i alt vesentlig fri for endogene enzymer som har (a) den samme funksjon og (b) den samme cellemembranintegrasjon eller mangel på integrasjon, som nevnte parasittenzymantigen eller fragment derav. En slik fremgangsmåte er særlig anvendelig for ekspresjon av integrale membranaminopeptidaseantigener fra innvollsormer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939302302A GB9302302D0 (en) | 1993-02-05 | 1993-02-05 | Process |
PCT/GB1994/000204 WO1994018320A1 (en) | 1993-02-05 | 1994-02-04 | Expression of protective antigens |
Publications (2)
Publication Number | Publication Date |
---|---|
NO953067D0 NO953067D0 (no) | 1995-08-04 |
NO953067L true NO953067L (no) | 1995-10-04 |
Family
ID=10729928
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953067A NO953067L (no) | 1993-02-05 | 1995-08-04 | Ekspresjon av beskyttende antigener |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0682702A1 (no) |
JP (1) | JPH08506726A (no) |
AU (1) | AU682488B2 (no) |
BG (1) | BG61574B1 (no) |
BR (1) | BR9406442A (no) |
CA (1) | CA2155120A1 (no) |
CZ (1) | CZ285042B6 (no) |
FI (1) | FI953682A0 (no) |
GB (1) | GB9302302D0 (no) |
HU (1) | HU219539B (no) |
NO (1) | NO953067L (no) |
NZ (1) | NZ261144A (no) |
PL (1) | PL178330B1 (no) |
RU (1) | RU2126045C1 (no) |
UA (1) | UA32437C2 (no) |
WO (1) | WO1994018320A1 (no) |
ZA (1) | ZA94740B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9209993D0 (en) * | 1992-05-08 | 1992-06-24 | Munn Edward A | Vaccines |
GB9322702D0 (en) | 1993-11-03 | 1993-12-22 | Agricultural & Food Res | Vaccines |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8619293D0 (en) * | 1986-08-07 | 1986-09-17 | Munn E A | Anthelmintic agents |
GB8906156D0 (en) * | 1989-03-17 | 1989-05-04 | Munn Edward A | Production and use of anthelmintic agents and protective immunogens |
JP2700088B2 (ja) * | 1991-07-25 | 1998-01-19 | 房則 濱島 | 免疫抑制剤 |
GB9209993D0 (en) * | 1992-05-08 | 1992-06-24 | Munn Edward A | Vaccines |
GB9322702D0 (en) * | 1993-11-03 | 1993-12-22 | Agricultural & Food Res | Vaccines |
-
1993
- 1993-02-05 GB GB939302302A patent/GB9302302D0/en active Pending
-
1994
- 1994-02-03 ZA ZA94740A patent/ZA94740B/xx unknown
- 1994-02-04 JP JP6517779A patent/JPH08506726A/ja active Pending
- 1994-02-04 BR BR9406442A patent/BR9406442A/pt not_active Application Discontinuation
- 1994-02-04 HU HU9502311A patent/HU219539B/hu not_active IP Right Cessation
- 1994-02-04 CA CA002155120A patent/CA2155120A1/en not_active Abandoned
- 1994-02-04 UA UA95083782A patent/UA32437C2/uk unknown
- 1994-02-04 PL PL94310109A patent/PL178330B1/pl unknown
- 1994-02-04 RU RU95120188A patent/RU2126045C1/ru active
- 1994-02-04 AU AU59753/94A patent/AU682488B2/en not_active Ceased
- 1994-02-04 NZ NZ261144A patent/NZ261144A/en unknown
- 1994-02-04 WO PCT/GB1994/000204 patent/WO1994018320A1/en not_active Application Discontinuation
- 1994-02-04 CZ CZ951994A patent/CZ285042B6/cs not_active IP Right Cessation
- 1994-02-04 EP EP94905785A patent/EP0682702A1/en not_active Withdrawn
-
1995
- 1995-08-02 FI FI953682A patent/FI953682A0/fi unknown
- 1995-08-04 NO NO953067A patent/NO953067L/no not_active Application Discontinuation
- 1995-08-28 BG BG99887A patent/BG61574B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
GB9302302D0 (en) | 1993-03-24 |
HUT72990A (en) | 1996-06-28 |
HU9502311D0 (en) | 1995-10-30 |
CZ199495A3 (en) | 1996-02-14 |
PL310109A1 (en) | 1995-11-27 |
FI953682A (fi) | 1995-08-02 |
NZ261144A (en) | 1998-02-26 |
CZ285042B6 (cs) | 1999-05-12 |
AU5975394A (en) | 1994-08-29 |
HU219539B (hu) | 2001-05-28 |
BR9406442A (pt) | 1996-02-27 |
UA32437C2 (uk) | 2000-12-15 |
CA2155120A1 (en) | 1994-08-18 |
NO953067D0 (no) | 1995-08-04 |
JPH08506726A (ja) | 1996-07-23 |
EP0682702A1 (en) | 1995-11-22 |
WO1994018320A1 (en) | 1994-08-18 |
BG61574B1 (en) | 1997-12-30 |
BG99887A (bg) | 1996-12-31 |
PL178330B1 (pl) | 2000-04-28 |
ZA94740B (en) | 1994-09-09 |
FI953682A0 (fi) | 1995-08-02 |
RU2126045C1 (ru) | 1999-02-10 |
AU682488B2 (en) | 1997-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Manoury et al. | An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation | |
Zito et al. | Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin | |
Vieillard et al. | NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand | |
Millar et al. | Mitochondrial cytochrome c oxidase and succinate dehydrogenase complexes contain plant specific subunits | |
Hehemann et al. | Bacteria of the human gut microbiome catabolize red seaweed glycans with carbohydrate-active enzyme updates from extrinsic microbes | |
Charlab et al. | Toward an understanding of the biochemical and pharmacological complexity of the saliva of a hematophagous sand fly Lutzomyia longipalpis | |
Acosta-Serrano et al. | The surface coat of procyclic Trypanosoma brucei: programmed expression and proteolytic cleavage of procyclin in the tsetse fly | |
Venugopal et al. | Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD (P) H: quinone oxidoreductase1 gene | |
MX9606476A (es) | Inhibicion citoplasmica de expresion de genes. | |
Klein et al. | Pineal Serotonin N-Acetyltransferase Activity: Abrupt Decrease in Adenosine 3′, 5′-Monophosphate May Be Signal for" Turnoff" | |
Cheng et al. | The 2B domain of the Escherichia coli Rep protein is not required for DNA helicase activity | |
GB9703406D0 (en) | Expression of heterologous proteins | |
SG141233A1 (en) | Control of gene expression | |
DE69534227D1 (de) | Stoffe und verfahren zur beherrschung der hyperakuten abstossung von menschlichen transplantaten | |
NO20050447L (no) | Isolering og identifisering av T-celler | |
Mourão et al. | Role of the endogenous antioxidant system in the protection of Schistosoma mansoni primary sporocysts against exogenous oxidative stress | |
Isaac et al. | Insect angiotensin‐converting enzyme: a processing enzyme with broad substrate specificity and a role in reproduction | |
Adamson et al. | Transcriptional activation of antioxidants may compensate for selenoprotein deficiencies in A mblyomma maculatum (A cari: I xodidae) injected with selK‐or selM‐dsRNA | |
Fukuda et al. | Cellular conservation of endangered midget buffalo (Lowland Anoa, Bubalus quarlesi) by establishment of primary cultured cell, and its immortalization with expression of cell cycle regulators | |
EP1135482A4 (en) | CANCER CELL VACCINE | |
Li et al. | Comparative analysis of iTRAQ-based proteome profiles of Schistosoma japonicum female worms coming from single-sex infections and bisexual infections | |
Liu et al. | Generation of Plasmodium yoelii malaria parasite for conditional degradation of proteins | |
Villar et al. | Expression of heat shock and other stress response proteins in ticks and cultured tick cells in response to Anaplasma spp. infection and heat shock | |
NO953067L (no) | Ekspresjon av beskyttende antigener | |
David et al. | Isoaspartate in ribosomal protein S11 of Escherichia coli |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |